Difference between revisions of "Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Third Author string (P151): Ma Wenbo, #quickstatements; #temporary_batch_1589999365427)
(‎Created claim: Fifth Author string (P153): Zhang Yu-Qian, #quickstatements; #temporary_batch_1590155508986)
 
(9 intermediate revisions by the same user not shown)
Property / Issue
 +
1
Property / Issue: 1 / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1186/s12865-014-0064-x / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 25636521 / rank
 +
Normal rank
Property / Publication Date
 +
2015
Timestamp+2015-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2015 / rank
 +
Normal rank
Property / Published In Name String
 +
BMC Immunology
Property / Published In Name String: BMC Immunology / rank
 +
Normal rank
Property / Volume
 +
16
Property / Volume: 16 / rank
 +
Normal rank
Property / title
 +
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English)
Property / title: Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English) / rank
 +
Normal rank
Property / Page(s)
 +
1-
Property / Page(s): 1- / rank
 +
Normal rank
Property / Fourth Author string
 +
Zhang Shuren
Property / Fourth Author string: Zhang Shuren / rank
 +
Normal rank
Property / Fifth Author string
 +
Zhang Yu-Qian
Property / Fifth Author string: Zhang Yu-Qian / rank
 +
Normal rank

Latest revision as of 13:53, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Deng Zhenling
    0 references
    Wu Yanhong
    0 references
    Ma Wenbo
    0 references
    1
    0 references
    0 references
    2015
    0 references
    BMC Immunology
    0 references
    16
    0 references
    Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English)
    0 references
    1-
    0 references
    Zhang Shuren
    0 references
    Zhang Yu-Qian
    0 references